10MO EMPOWER-Lung 1: Cemiplimab (CEMI) Monotherapy As First-Line (1L) Treatment of Patients (pts) with Brain Metastases from Advanced Non-Small Cell Lung Cancer (ansclc) with Programmed Cell Death-Ligand 1 (PD-L1) ≥50% — 3-Year Update
Journal of thoracic oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要